APx Acquisition Corp. I
Status: Live Deal
U=S+W/2
W=S@11.5
IPO Proceeds, $M | $172.50M |
---|---|
IPO Date | Dec 7, 2021 |
CEO | Kyle P. Bransfield |
Left Lead | BofA Securities |
IPO Cash in Trust | 102.0% |
SPAC Tenor | 15 + 3 + 3 + 3 + 12 |
IPO Sector |
General
Companies in a Spanish-speaking Latin American country (“SSLA”) or companies outside a SSLA that provide goods and services to Spanish speaking markets |
IPO Geography | LatAm |
Target Company | OmnigenicsAI Corp |
Deal Announced | TBD |
Deal Size, $M | $340.00M |
Deal Sector | Healthcare |
Deal Geography | Global |
SEC Filings | www.sec.gov |
Approval Vote | TBD |
Amendment Vote | Dec 8, 2023 |
APXI
APXIU
APXIW
Price | $11.83 |
---|---|
Last closing price | $11.86 |
H/L, today | $11.83 / $11.85 |
H/L, 52-week | $9.86 / $11.04 |
Volume, today | 601 |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on APx Acquisition Corp. I:
- Structure and cap table
- 7 directors & officers
- 25 filings and events
- 1 underwriters
- 1 deal advisors
- 7 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Kyle P. Bransfield | 40 | CEO and Chairman |
Xavier Martinez | 32 | CFO |
Alfredo Vara Alonso | 55 | Director |
Daniel Braatz | 40 | Director |
Daniel Mudd | 65 | Director |
Fara Remtulla | 51 | Director |
Thomas P.M. Barry | 41 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
BofA Securities | BR | 15,000,000 | units |
15,000,000 | units | ||
Up-Front UW fee | 2.00 | % | |
Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.